Search Results 191-200 of 12708 for Assay
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...
This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...
The assay quantifies the fraction of dd-cfDNA in both unrelated and related ... Application of the assay to clinical samples from heart transplant ...
Johnson C, Marquez C, Olson D, Ward T, Cheney S, Hulten T, Ton T, Webb CR, Dunn J. Development and performance of a multiplex PCR assay for the detection of ...
Natera has developed an assay called Prospera™ to detect the amount of donor-derived cell-free DNA (dd-cfDNA), which is a marker of kidney rejection.
“The assay can be really useful in knowing which genes are at those breakpoints because current chromosome studies cannot provide that level of resolution.
... assay developed by Mayo Medical laboratories. in patients with endogenous CS and in patients in whom CS was suspected but diagnosis rejected. 2. To compare ...
The research interests of Mayo Clinic's Alicia Algeciras-Schimnich, Ph.D., focus on biofluid biomarker assays to diagnose Alzheimer's disease and other ...
The core is also able to perform enzyme-linked immunosorbent assay (ELISA) screening of the serum. More about research at Mayo Clinic. Research Faculty ...
... assays. Under the leadership of director Akhilesh Pandey, M.D., Ph.D., the scientists at the core not only offer routine services to identify and quantify ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.